Can Asthma Get Worse With Age?

Explore how aging lungs, new comorbidities, and diagnostic challenges impact the trajectory and management of asthma in older adults.

Asthma can absolutely get worse with age, and for a sizable number of people it does. The reasons go well beyond “getting older means getting sicker.” Normal aging changes the lungs and immune system in specific ways that make asthma harder to control, and conditions that accumulate over a lifetime, from weight gain to occupational dust exposure, can compound the problem. Whether your asthma has been around since childhood or showed up for the first time at fifty, the trajectory is shaped by biology, hormones, inflammation patterns, and how well the disease gets recognized and treated in the first place.

How Aging Changes Your Lungs and Immune System

Even in healthy people, lung function gradually declines after the mid-twenties. The chest wall stiffens, the diaphragm weakens slightly, and the small airways lose some of their elastic recoil. For someone with asthma, these normal changes land on top of airways that are already prone to narrowing and inflammation. One study tracking adults who developed asthma at different life stages found that the rate of lung-function decline roughly tripled between younger and older groups: young adults lost about 11 milliliters of lung capacity per year, middle-aged adults about 18, and older adults about 31. That extra loss adds up fast over a decade or two.

Chronic asthma also causes its own structural damage. Repeated bouts of inflammation lead to what researchers call airway remodeling: the smooth muscle lining the airways thickens, the tissue beneath the airway surface becomes more fibrous, and the epithelial cells that normally act as a protective barrier break down more easily. These changes are not fully reversible with medication, and they accumulate over time. The longer someone has had asthma, the more remodeling has had a chance to occur, which is one reason longtime asthmatics sometimes find their baseline breathing slowly getting worse even when flare-ups are well managed.

On top of structural changes, the immune system itself ages. The term for this is immunosenescence, and it involves a shift toward more chronic, low-grade inflammation throughout the body. In the lungs specifically, aging immune cells become less efficient at clearing infections and more prone to pumping out inflammatory signals. This background inflammation can worsen existing asthma and may even trigger new-onset asthma in people who never had it before. Research on the airway smooth muscle cells of elderly asthmatics has found elevated markers of cellular senescence, including factors that promote both inflammation and tissue scarring.

A Different Kind of Inflammation in Older Airways

Asthma is not one disease with one pattern of inflammation. In children and younger adults, the airway inflammation is often driven by eosinophils, a type of white blood cell linked to allergic responses. In older adults, the picture shifts. Multiple studies have found that sputum samples from elderly asthmatics contain significantly more neutrophils, a different class of inflammatory cell. One study found the percentage of sputum neutrophils was about 57% in older asthmatics compared with 37% in younger ones. Other work has confirmed a higher proportion of neutrophilic and mixed-pattern asthma in older age groups, with a corresponding drop in purely eosinophilic and low-inflammation subtypes.

This matters for a practical reason: neutrophilic inflammation does not respond as well to inhaled corticosteroids, the backbone of standard asthma treatment. So not only does the inflammation change character as you age, but the shift can make your usual medications less effective. That mismatch between the type of inflammation and the type of treatment is a major contributor to worsening control in older asthmatics.

Why Adult-Onset Asthma Tends to Be More Persistent

A common pattern in childhood asthma is that many kids improve or go into remission by their teens or twenties. Adult-onset asthma behaves differently. It remits far less often, relapses more frequently, and tends to involve more day-to-day symptoms and greater medication use. Adults who develop asthma for the first time are also more likely to have the non-allergic form, meaning their disease is not driven by classic allergens like pollen or dust mites. Non-allergic asthma tends to be more severe and is linked to a faster decline in lung function.

Even people who had asthma as children and thought they outgrew it sometimes see it return in midlife or later, often in a harder-to-manage form. Years of cumulative environmental exposure, hormonal changes, and the immune shifts described above can reactivate a disease that had been dormant. The returning version frequently looks different from the childhood version, with less allergic sensitivity but more fixed airway obstruction.

The Hormonal Connection

Before puberty, boys are more likely to have asthma than girls. After puberty, the ratio flips, and women carry a higher burden of asthma through adulthood. The hormonal shifts around menopause are a particularly critical window. A study of asthmatic women found that menopause was a significant predictor of more severe disease, with an odds ratio above 5 for severity when other factors were accounted for. The peak age for asthma exacerbations in women occurs around age 50, which aligns with the average age of menopause. One large study of about 1,200 asthmatic women found that significant respiratory symptoms were nearly twice as common during the perimenopausal period and that lung function dropped by about 150 milliliters.

The mechanism is not fully settled, but estrogen appears to have complex effects on airway inflammation, and the fluctuations and eventual decline in estrogen levels during perimenopause and menopause may remove a partially protective effect. For women who have had stable asthma for years, this hormonal transition can feel like a sudden, unexplained worsening.

Comorbidities That Make Asthma Harder to Control

Aging tends to bring along other health conditions, and several of them interact directly with asthma. Obesity, obstructive sleep apnea, and gastroesophageal reflux are three that come up repeatedly in the research. These conditions share inflammatory pathways with asthma and may independently worsen airway inflammation or trigger symptoms that mimic asthma flare-ups.

Obesity is a particularly strong player. In people whose asthma began in adulthood, obesity was the comorbidity most closely associated with poor asthma control. It was linked to worse lung function, higher neutrophil counts, and uncontrolled disease in a way that was not seen for obesity in early-onset asthma. Excess weight compresses the lungs mechanically, promotes systemic inflammation, and may alter the composition of the airway microbiome. Sleep apnea, which often accompanies obesity, was associated with worse asthma control scores in obese patients, though reflux alone showed less of an independent effect on asthma control in one study.

The broader point is that managing asthma in an older adult is rarely just about managing asthma. Conditions that seem unrelated to the lungs, from acid reflux to diabetes, can each tug asthma control in the wrong direction.

Workplace Exposures and Late-Onset Severity

Years of workplace exposure to certain chemicals, dusts, and biological agents can either trigger asthma for the first time or push existing asthma toward greater severity. One study found that exposure to occupational asthma-causing agents was associated with a fourfold increase in the odds of severe adult-onset asthma, and exposure in mixed industrial environments raised the odds more than sevenfold. These associations were specific to adult-onset disease and were not seen for childhood-onset asthma or mild adult cases.

A cohort study following people over fifty years found that exposure to food-related allergens and biocides in the workplace was associated with adult-onset wheezing and reduced lung function, with a clear dose-response pattern: the more exposure, the worse the outcomes. Workers in these categories showed an excess lung-function decline of about 6 to 8 milliliters per year above and beyond the normal age-related loss. If you have been in an occupation involving industrial cleaners, wood dust, agricultural chemicals, or food-processing allergens for decades, cumulative exposure is a plausible explanation for worsening symptoms in midlife and beyond.

When Asthma and COPD Start to Look Alike

One of the most frustrating aspects of asthma in older adults is that it becomes genuinely difficult to tell apart from chronic obstructive pulmonary disease. In textbook terms, asthma involves reversible airway obstruction and COPD involves fixed obstruction, but in practice the line blurs with age. Long-standing asthma can develop a fixed component through years of remodeling, and COPD patients can have some reversibility. Older former smokers with partially reversible airflow obstruction and some allergic features represent a common “overlap” scenario that does not fit neatly into either box.

This diagnostic ambiguity has real consequences. Older adults with asthma are frequently underdiagnosed or misdiagnosed with COPD, congestive heart failure, or simply “aging lungs.” Classic asthma symptoms like episodic wheezing and chest tightness are nonspecific in this age group, and older patients tend to underrate their symptoms. If asthma is missed entirely, the patient does not get the anti-inflammatory treatment that could slow the disease’s progression. If asthma is misdiagnosed as COPD, the treatment approach may be subtly wrong: COPD treatment emphasizes long-acting bronchodilators, while asthma treatment hinges on anti-inflammatory control. Getting the diagnosis right matters more with age, not less.

Why Standard Treatments Can Fall Short

Older adults are significantly underrepresented in clinical trials for asthma medications, which means the treatments prescribed to them were mostly tested in younger populations. Subgroup analyses of the large trials that do include elderly patients suggest they may be less likely to respond to inhaled corticosteroids. The shift toward neutrophilic inflammation described earlier is part of the explanation, since corticosteroids primarily target eosinophilic pathways.

There are also practical barriers. Studies of elderly asthma patients have found high frequencies of poor inhaler technique, low medication adherence, and cognitive impairment, all of which undermine treatment effectiveness regardless of how well the drug works in theory. Arthritis in the hands can make pressing a metered-dose inhaler difficult. Reduced inspiratory flow means dry-powder inhalers may not deliver the drug effectively. And polypharmacy is a constant concern: older adults often take medications for heart disease, blood pressure, or other conditions that may interact with asthma drugs or even worsen airway symptoms. Beta-blockers, for instance, can provoke bronchospasm in susceptible individuals.

The good news is that newer biologic therapies, drugs that target specific inflammatory molecules, are showing promise even in older patients. Biologics like omalizumab, mepolizumab, and dupilumab have been studied primarily in younger adults, but observational data from older patients suggest similar benefits in terms of reducing flare-ups and improving control. A real-world retrospective study confirmed that biologic therapy in older asthma patients could be continued safely and effectively at rates comparable to younger patients. These therapies are not widely used in elderly populations yet, partly because of the research gap, but the early signals are encouraging.

Exercise and Pulmonary Rehabilitation

Medications are only part of the picture, and for older adults dealing with worsening asthma, structured exercise programs deserve attention. A Cochrane review found that pulmonary rehabilitation improved functional exercise capacity by about 80 meters on a six-minute walk test compared to usual care, a difference that exceeds the threshold for a meaningful clinical improvement. There were also gains in asthma control scores, though the evidence for that outcome was less certain. Other reviews have noted benefits at any stage of the disease, including reductions in wheezing, anxiety, and airway inflammation.

Programs that combine exercise with education and self-management skills appear to produce the most consistent improvements, particularly in patients whose asthma is poorly controlled. For older adults who are afraid that exercise will trigger an attack, the supervised environment of a pulmonary rehab program can provide both physical benefits and the confidence to stay active, which itself helps maintain lung capacity over time.

Asthma Mortality in Older Adults

Deaths from asthma are rare overall, but they are disproportionately concentrated in older adults. A study of U.S. mortality data from 1999 to 2020 found that asthma death rates climbed steeply with age: in the most recent year of data, rates were about 1.9 per 100,000 in the 65-to-74 group, roughly 3.3 in the 75-to-84 group, and about 8.4 in those 85 and older. Rates dropped substantially over that two-decade span across all age groups, likely due to better treatments and broader access to care, but they remain far higher than in younger adults. Women had higher asthma mortality than men in every age bracket, consistent with the broader pattern of more severe disease in women after puberty.

These numbers reinforce a point that runs through the research: asthma in older adults is not a trivial or waning condition. It is underdiagnosed, undertreated, and still killing people at rates that are multiples of what is seen in younger populations. The encouraging trend is that mortality is heading down, but the persistent age gradient means there is still a long way to go in getting older adults the right diagnosis and the right treatment early enough to prevent the worst outcomes.

The Gut Microbiome and Aging Lungs

An emerging and still speculative area of research involves the relationship between the gut microbiome and airway inflammation. Animal studies have found that the composition of intestinal bacteria changes with age in ways that may amplify inflammatory responses in the lungs. In older mice, these microbial shifts were associated with exaggerated pulmonary inflammation when the animals were exposed to allergens. Whether this translates directly to human asthma is still unclear, and no one should be treating their asthma with probiotics based on mouse data. But the finding points to a broader truth about aging and asthma: the disease sits at the intersection of airway biology, systemic inflammation, immune aging, and metabolic health, and all of these change as you get older. The simple framing of asthma as a single allergic condition of the airways becomes less and less accurate with every decade of life.